BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 13, 2026
Home
»
Authors
» Jennifer Boggs
Jennifer Boggs
Articles
ARTICLES
Speedel Presents Confirmatory Positive SPP301 Phase II Data
Nov. 15, 2005
By
Jennifer Boggs
Speedel Presents Confirmatory Positive SPP301 Phase II Data
Nov. 15, 2005
By
Jennifer Boggs
Aphton Ends Sanofi Deal, Seeks New Insegia Partner
Nov. 11, 2005
By
Jennifer Boggs
PTC Raises $26M Privately; Lead Drug To Start Phase II
Nov. 11, 2005
By
Jennifer Boggs
Aphton Ends Sanofi Deal, Seeks New Insegia Partner
Nov. 11, 2005
By
Jennifer Boggs
PTC Raises $26M Privately; Lead Drug To Start Phase II
Nov. 11, 2005
By
Jennifer Boggs
Versant Closes $400M Fund, Seeks Early Stage Companies
Nov. 10, 2005
By
Jennifer Boggs
Versant Closes $400M Fund, Seeks Early Stage Companies
Nov. 10, 2005
By
Jennifer Boggs
With Lucentis BLA In Works, Genentech Reports AMD Data
Nov. 9, 2005
By
Jennifer Boggs
With Lucentis BLA In Works, Genentech Reports AMD Data
Nov. 9, 2005
By
Jennifer Boggs
View All Articles by Jennifer Boggs
